Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alka Bansal

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Bioorganic & Medicinal Chemistry Letters|September 27, 2020
Soluble guanylate cyclase stimulators for the treatment of hypertension: Discovery of MK-2947Linda Brockunier, John Stelmach, Jian Guo, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Design of a novel pyrrolidine scaffold utilized in the discovery of potent and selective human β3 adrenergic receptor agonistsGregori J Morriello, Harvey R Wendt, Alka Bansal, et al.
Journal of Medicinal Chemistry|January 21, 2014
Design, synthesis, and evaluation of conformationally restricted acetanilides as potent and selective β3 adrenergic receptor agonists for the treatment of overactive bladderChristopher R Moyes, Richard Berger, Stephen D Goble, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Bioorganic & Medicinal Chemistry Letters|September 27, 2020
Soluble guanylate cyclase stimulators for the treatment of hypertension: Discovery of MK-2947Linda Brockunier, John Stelmach, Jian Guo, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Design of a novel pyrrolidine scaffold utilized in the discovery of potent and selective human β3 adrenergic receptor agonistsGregori J Morriello, Harvey R Wendt, Alka Bansal, et al.
Journal of Medicinal Chemistry|January 21, 2014
Design, synthesis, and evaluation of conformationally restricted acetanilides as potent and selective β3 adrenergic receptor agonists for the treatment of overactive bladderChristopher R Moyes, Richard Berger, Stephen D Goble, et al.
Pageof 2